Highlights

[KERJAYA] QoQ Quarter Result on 2011-09-30 [#3]

Stock [KERJAYA]: KERJAYA PROSPEK GROUP BHD
Announcement Date 21-Nov-2011
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 30-Sep-2011  [#3]
Profit Trend QoQ -     1,297.28%    YoY -     529.22%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 46,199 79,885 48,858 48,889 27,914 12,925 8,604 206.95%
  QoQ % -42.17% 63.50% -0.06% 75.14% 115.97% 50.22% -
  Horiz. % 536.95% 928.46% 567.85% 568.21% 324.43% 150.22% 100.00%
PBT 6,060 6,216 1,810 2,634 667 -405 -3,802 -
  QoQ % -2.51% 243.43% -31.28% 294.90% 264.69% 89.35% -
  Horiz. % -159.39% -163.49% -47.61% -69.28% -17.54% 10.65% 100.00%
Tax -570 -416 1,495 -63 -483 -87 47 -
  QoQ % -37.02% -127.83% 2,473.02% 86.96% -455.17% -285.11% -
  Horiz. % -1,212.77% -885.11% 3,180.85% -134.04% -1,027.66% -185.11% 100.00%
NP 5,490 5,800 3,305 2,571 184 -492 -3,755 -
  QoQ % -5.34% 75.49% 28.55% 1,297.28% 137.40% 86.90% -
  Horiz. % -146.21% -154.46% -88.02% -68.47% -4.90% 13.10% 100.00%
NP to SH 5,490 5,800 3,305 2,571 184 -492 -3,755 -
  QoQ % -5.34% 75.49% 28.55% 1,297.28% 137.40% 86.90% -
  Horiz. % -146.21% -154.46% -88.02% -68.47% -4.90% 13.10% 100.00%
Tax Rate 9.41 % 6.69 % -82.60 % 2.39 % 72.41 % - % - % -
  QoQ % 40.66% 108.10% -3,556.07% -96.70% 0.00% 0.00% -
  Horiz. % 13.00% 9.24% -114.07% 3.30% 100.00% - -
Total Cost 40,709 74,085 45,553 46,318 27,730 13,417 12,359 121.54%
  QoQ % -45.05% 62.63% -1.65% 67.03% 106.68% 8.56% -
  Horiz. % 329.39% 599.44% 368.58% 374.77% 224.37% 108.56% 100.00%
Net Worth 60,798 55,367 48,993 91,756 27,303 26,942 27,596 69.40%
  QoQ % 9.81% 13.01% -46.61% 236.06% 1.34% -2.37% -
  Horiz. % 220.31% 200.63% 177.53% 332.49% 98.94% 97.63% 100.00%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div - - - - - - - -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 60,798 55,367 48,993 91,756 27,303 26,942 27,596 69.40%
  QoQ % 9.81% 13.01% -46.61% 236.06% 1.34% -2.37% -
  Horiz. % 220.31% 200.63% 177.53% 332.49% 98.94% 97.63% 100.00%
NOSH 90,743 90,766 90,727 90,848 59,354 58,571 58,715 33.71%
  QoQ % -0.03% 0.04% -0.13% 53.06% 1.34% -0.25% -
  Horiz. % 154.55% 154.59% 154.52% 154.72% 101.09% 99.75% 100.00%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 11.88 % 7.26 % 6.76 % 5.26 % 0.66 % -3.81 % -43.64 % -
  QoQ % 63.64% 7.40% 28.52% 696.97% 117.32% 91.27% -
  Horiz. % -27.22% -16.64% -15.49% -12.05% -1.51% 8.73% 100.00%
ROE 9.03 % 10.48 % 6.75 % 2.80 % 0.67 % -1.83 % -13.61 % -
  QoQ % -13.84% 55.26% 141.07% 317.91% 136.61% 86.55% -
  Horiz. % -66.35% -77.00% -49.60% -20.57% -4.92% 13.45% 100.00%
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 50.91 88.01 53.85 53.81 47.03 22.07 14.65 129.60%
  QoQ % -42.15% 63.44% 0.07% 14.42% 113.09% 50.65% -
  Horiz. % 347.51% 600.75% 367.58% 367.30% 321.02% 150.65% 100.00%
EPS 6.05 6.39 4.27 2.83 0.31 -0.84 -6.39 -
  QoQ % -5.32% 49.65% 50.88% 812.90% 136.90% 86.85% -
  Horiz. % -94.68% -100.00% -66.82% -44.29% -4.85% 13.15% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.6700 0.6100 0.5400 1.0100 0.4600 0.4600 0.4700 26.69%
  QoQ % 9.84% 12.96% -46.53% 119.57% 0.00% -2.13% -
  Horiz. % 142.55% 129.79% 114.89% 214.89% 97.87% 97.87% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,241,968
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 3.72 6.43 3.93 3.94 2.25 1.04 0.69 207.78%
  QoQ % -42.15% 63.61% -0.25% 75.11% 116.35% 50.72% -
  Horiz. % 539.13% 931.88% 569.57% 571.01% 326.09% 150.72% 100.00%
EPS 0.44 0.47 0.27 0.21 0.01 -0.04 -0.30 -
  QoQ % -6.38% 74.07% 28.57% 2,000.00% 125.00% 86.67% -
  Horiz. % -146.67% -156.67% -90.00% -70.00% -3.33% 13.33% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.0490 0.0446 0.0394 0.0739 0.0220 0.0217 0.0222 69.60%
  QoQ % 9.87% 13.20% -46.68% 235.91% 1.38% -2.25% -
  Horiz. % 220.72% 200.90% 177.48% 332.88% 99.10% 97.75% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 0.8800 0.8000 0.5300 0.5000 0.5000 0.4700 0.3700 -
P/RPS 1.73 0.91 0.98 0.93 1.06 2.13 2.52 -22.20%
  QoQ % 90.11% -7.14% 5.38% -12.26% -50.23% -15.48% -
  Horiz. % 68.65% 36.11% 38.89% 36.90% 42.06% 84.52% 100.00%
P/EPS 14.55 12.52 14.55 17.67 161.29 -55.95 -5.79 -
  QoQ % 16.21% -13.95% -17.66% -89.04% 388.28% -866.32% -
  Horiz. % -251.30% -216.23% -251.30% -305.18% -2,785.66% 966.32% 100.00%
EY 6.88 7.99 6.87 5.66 0.62 -1.79 -17.28 -
  QoQ % -13.89% 16.30% 21.38% 812.90% 134.64% 89.64% -
  Horiz. % -39.81% -46.24% -39.76% -32.75% -3.59% 10.36% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.31 1.31 0.98 0.50 1.09 1.02 0.79 40.14%
  QoQ % 0.00% 33.67% 96.00% -54.13% 6.86% 29.11% -
  Horiz. % 165.82% 165.82% 124.05% 63.29% 137.97% 129.11% 100.00%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 28/08/12 15/06/12 29/02/12 21/11/11 22/08/11 27/05/11 28/02/11 -
Price 0.8500 0.8700 0.9200 0.5200 0.4600 0.5500 0.3500 -
P/RPS 1.67 0.99 1.71 0.97 0.98 2.49 2.39 -21.27%
  QoQ % 68.69% -42.11% 76.29% -1.02% -60.64% 4.18% -
  Horiz. % 69.87% 41.42% 71.55% 40.59% 41.00% 104.18% 100.00%
P/EPS 14.05 13.62 25.26 18.37 148.39 -65.48 -5.47 -
  QoQ % 3.16% -46.08% 37.51% -87.62% 326.62% -1,097.08% -
  Horiz. % -256.86% -248.99% -461.79% -335.83% -2,712.80% 1,197.08% 100.00%
EY 7.12 7.34 3.96 5.44 0.67 -1.53 -18.27 -
  QoQ % -3.00% 85.35% -27.21% 711.94% 143.79% 91.63% -
  Horiz. % -38.97% -40.18% -21.67% -29.78% -3.67% 8.37% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.27 1.43 1.70 0.51 1.00 1.20 0.74 43.39%
  QoQ % -11.19% -15.88% 233.33% -49.00% -16.67% 62.16% -
  Horiz. % 171.62% 193.24% 229.73% 68.92% 135.14% 162.16% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS